Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Blood Pressure Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (End Use, Device Type, Connectivity), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 5568| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Blood Pressure Monitoring Devices Market size was valued at USD 4.6 billion in 2026 and is anticipated to grow at a 8.84% CAGR from 2027 to 2036, attaining USD 10.73 billion by 2036. The industry revenue for 2027 is assessed at USD 4.94 billion.

Base Year Value (2026)
USD 4.6 billion
CAGR (2027-2036)
8.84%
Forecast Year Value (2036)
USD 10.73 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Blood Pressure Monitoring Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 37.92% market share in 2026, supported by strong home monitoring adoption, established screening practices, mature healthcare systems, and broad availability of connected devices.
  • Asia Pacific is projected to grow at an 11.07% CAGR, fueled by rising hypertension detection, expanding healthcare access, and increasing consumer adoption of affordable digital blood pressure monitors for home use.

Segment Momentum

  • Non-Smart/Traditional devices lead the market due to their broad familiarity, ease of use, and established role in routine blood pressure measurement across both clinical and personal monitoring settings.
  • Smart devices are the fastest-growing segment because they support connected health management and ongoing tracking. Their ability to integrate monitoring with digital care routines is increasing adoption among users seeking accessible health data.

Market Expansion Drivers

  • Rising hypertension prevalence driven by sedentary lifestyles and aging populations.
  • Expansion of hospital-based monitoring and integrated diagnostic solutions.
  • Growth of home-based remote patient monitoring and connected healthcare ecosystems.

Leading Market Participants

  • Major players in the blood pressure monitoring devices market include Omron Healthcare Co., Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Welch Allyn, Inc. (United States), A&D Company, Limited (Japan), SunTech Medical, Inc. (United States), Microlife Corporation (Taiwan), Rossmax International Ltd. (Taiwan), Spacelabs Healthcare, Inc. (United States), B. Braun SE (Germany).

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 4.6 billion
  • 2027 Estimated Market Size: USD 4.94 billion.
  • Projected Market Size: USD 10.73 billion by 2036
  • Growth Forecast: 8.84% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | Non-Smart/Traditional (Device Type) | Non-Connected (Connectivity)
  • Emerging Opportunity Segment: Homecare (End Use) | Smart (Device Type) | Connected (Connectivity)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising hypertension prevalence driven by sedentary lifestyles and aging populations

Increasing hypertension prevalence associated with aging demographics, reduced physical activity, and lifestyle-related risk factors is creating sustained demand for regular blood pressure assessment, supporting growth in the blood pressure monitoring devices market. Older adults are particularly likely to require repeated measurements because blood pressure management often involves long-term observation and treatment adjustments. At the same time, greater awareness of cardiovascular risk is encouraging more frequent screening among broader population groups, expanding the use of blood pressure measurement devices across clinical settings, pharmacies, community health programs, and individual households.

Expansion of hospital-based monitoring and integrated diagnostic solutions

Hospitals are increasingly adopting monitoring technologies that can provide reliable blood pressure measurements as part of broader diagnostic and patient observation workflows, strengthening the blood pressure monitoring devices market. Blood pressure assessment is routinely incorporated into emergency care, inpatient monitoring, surgical procedures, and chronic disease evaluation, creating demand for devices that can operate efficiently alongside other clinical systems. Integration with multiparameter monitors and electronic clinical workflows can also streamline the collection and interpretation of vital signs, allowing healthcare professionals to assess blood pressure alongside other physiological indicators during patient evaluation.

Growth of home-based remote patient monitoring and connected healthcare ecosystems

The expansion of connected healthcare is moving blood pressure measurement beyond clinical environments, as home-based monitoring becomes an important component of long-term disease management and follow-up care. This trend will boost blood pressure monitoring devices market demand by enabling patients to record measurements regularly and share readings with healthcare professionals through connected platforms. Wireless connectivity, smartphone integration, and remote data access can support more consistent monitoring while helping clinicians identify changes between appointments, particularly for patients managing hypertension over extended periods.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising hypertension prevalence driven by sedentary lifestyles and aging populations 2.40% High North America, Europe High Near Term
Expansion of hospital-based monitoring and integrated diagnostic solutions 2.10% Moderate North America, Asia Pacific High Mid Term
Growth of home-based remote patient monitoring and connected healthcare ecosystems 1.80% Moderate North America, Asia Pacific Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
37.92% Market Share in 2026

North America (Largest Region)

In the blood pressure monitoring devices market, North America accounted for the largest share of 37.92% in 2026. High awareness of cardiovascular health, established healthcare systems, and widespread use of home-based monitoring devices support the region’s strong market position. Increasing emphasis on preventive healthcare and routine blood pressure management is encouraging demand among both healthcare professionals and consumers. Technological advancements in connected and digital monitoring solutions are further supporting adoption by enabling convenient tracking and improved integration of patient data into healthcare management.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is experiencing the fastest growth, driven by expanding healthcare access, increasing awareness of hypertension management, and the gradual shift toward preventive and home-based care. Improvements in healthcare infrastructure and greater availability of affordable monitoring technologies are broadening access to blood pressure measurement. Growing adoption of digital health tools and increasing demand for convenient self-monitoring are also creating favorable conditions for market expansion across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Preventive Health Adoption

Germany focuses on preventive cardiovascular care, driving consistent use of clinically validated blood pressure monitoring devices in both primary care and home settings. Healthcare providers in Germany emphasize accuracy standards and integration with digital health records.

France 🇫🇷

Primary Care Integration

France emphasizes the use of blood pressure monitoring devices within primary care and pharmacy-led health screening programs. Device adoption in France is supported by increasing focus on early diagnosis and routine cardiovascular assessment.

Italy 🇮🇹

Community Health Monitoring

Italy is expanding blood pressure monitoring use through community healthcare programs and home-based care initiatives. Providers in Italy prioritize affordable, easy-to-use devices that support ongoing management of cardiovascular conditions.

Japan 🇯🇵

Self-Monitoring Culture

Japan demonstrates strong adoption of daily self-monitoring practices, with blood pressure devices widely used for routine health tracking. Manufacturers in Japan prioritize compact design, ease of use, and long-term reliability for elderly consumers.

South Korea 🇰🇷

Digital Health Tracking

South Korea integrates blood pressure monitoring devices into broader digital wellness ecosystems, with strong uptake of app-connected devices. Healthcare providers in South Korea encourage continuous monitoring to support early detection of hypertension risks.

United States 🇺🇸

Home Health Expansion

In the U.S., blood pressure monitoring devices are increasingly used in home-based chronic care management and telehealth programs. Manufacturers are emphasizing connected devices that integrate with mobile apps and healthcare platforms to support continuous cardiovascular tracking.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Blood Pressure Monitoring Devices Market Share (%), by End Use, 2026

Hospitals
Homecare
Ambulatory Surgical Centers & Clinics

Go beyond the chart, access full insights & data tables

Request Free Sample Report

End Use Segment Analysis: Hospitals (Largest Segment) vs Homecare (Fastest-Growing Segment)

Hospitals dominated the blood pressure monitoring devices market in 2026, accounting for a 54.67% share, supported by the routine need for accurate blood pressure assessment across inpatient care, emergency services, surgical procedures, and chronic disease management. Hospitals rely on established monitoring protocols and clinically validated devices to support timely diagnosis and continuous assessment of patients with cardiovascular and other conditions. The concentration of specialized healthcare professionals and the growing emphasis on regular vital-sign monitoring further reinforce hospitals as a key end-use setting.

Homecare is the fastest-growing segment as blood pressure management increasingly shifts toward convenient monitoring outside conventional clinical environments. The rising prevalence of chronic cardiovascular conditions and greater emphasis on preventive health are encouraging patients and caregivers to monitor blood pressure more regularly at home. Improved device usability and the growing acceptance of self-monitoring also support earlier identification of changes in blood pressure, strengthening demand for home-based monitoring solutions.

Device Type Segment Analysis: Non-Smart/Traditional (Largest Segment) vs Smart (Fastest-Growing Segment)

The non-smart/traditional segment held the largest share of the blood pressure monitoring devices market in 2026, reflecting the continued use of established blood pressure measurement technologies across healthcare facilities and household settings. Their straightforward operation, familiarity among healthcare professionals, and suitability for routine measurements support broad adoption. Reliability and accessibility remain important considerations in blood pressure assessment, particularly where advanced digital connectivity is not essential.

Smart devices are expanding at the fastest pace as consumers and healthcare providers place greater emphasis on connected health monitoring and longitudinal patient management. Digital connectivity can facilitate the recording, organization, and sharing of blood pressure readings, supporting more informed discussions between patients and healthcare professionals. Increasing interest in remote monitoring, personalized care, and technology-enabled disease management is therefore strengthening demand for smart blood pressure monitoring solutions.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Hospitals, Ambulatory Surgical Centers & Clinics, Homecare Hospitals Homecare
Device Type Non-Smart/Traditional, Smart Non-Smart/Traditional Smart
Connectivity Non-Connected, Connected, Wi-Fi-based, Bluetooth-based Non-Connected Connected
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the blood pressure monitoring devices market:

1. Omron Healthcare Co. Ltd. (Japan)

2. Koninklijke Philips N.V. (Netherlands)

3. GE HealthCare Technologies Inc. (United States)

4. Welch Allyn Inc. (United States)

5. A&D Company Limited (Japan)

6. SunTech Medical Inc. (United States)

7. Microlife Corporation (Taiwan)

8. Rossmax International Ltd. (Taiwan)

9. Spacelabs Healthcare Inc. (United States)

10. B. Braun SE (Germany)

The blood pressure monitoring devices market is experiencing increased innovation driven by rising consumer interest in preventive healthcare and connected wellness technologies. Manufacturers are introducing compact, app-enabled, and AI-supported monitoring solutions that enhance usability and tracking accuracy. The growing preference for home-based healthcare monitoring is further encouraging the development of portable and digitally integrated blood pressure monitoring devices.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Omron Healthcare Co. Ltd. (Japan)
Koninklijke Philips N.V. (Netherlands)
GE HealthCare Technologies Inc. (United States)
Welch Allyn Inc. (United States)
A&D Company Limited (Japan)
SunTech Medical Inc. (United States)
Microlife Corporation (Taiwan)
Rossmax International Ltd. (Taiwan)
Spacelabs Healthcare Inc. (United States)
B. Braun SE (Germany).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Huawei Jul-25 Huawei released a global software update for its Watch D2 wearable to optimize its blood pressure monitoring functionality. This update reflects the company’s strategic commitment to expanding its wearable health technology portfolio and improving the real-time cardiovascular data tracking capabilities available to global consumers.
MPR Jul-25 A new FDA-cleared cuffless blood pressure monitoring device has been introduced as a wearable band capable of continuous 24-hour tracking. This non-invasive, ambulatory solution facilitates improved long-term hypertension management by capturing blood pressure fluctuations across daily and nocturnal cycles, bypassing the limitations associated with traditional cuff-based measurement systems.
Tenovi May-25 Tenovi has launched a cellular-connected blood pressure monitor designed to support remote cardiovascular care and stroke prevention. By enabling continuous monitoring of blood pressure and irregular heart rhythms, the platform allows clinicians to detect hypertension earlier, providing a scalable solution for healthcare providers to manage patient health outcomes remotely.
Huawei Mar-25 Huawei has officially debuted the Watch D2 in the Indian market, bringing medical-grade blood pressure monitoring to the consumer smartwatch segment. The device utilizes advanced sensors and a specialized integrated mechanism to achieve higher measurement accuracy than conventional optical wearable sensors, marking a shift toward the integration of clinical-grade diagnostics into mainstream wearable technology.
CU Denver Mar-25 Researchers at CU Denver have developed a non-invasive wearable blood pressure monitor utilizing smart technology. The innovation focuses on integrating continuous cardiovascular tracking into portable platforms, supporting the broader transition toward digital health solutions and remote patient monitoring systems aimed at more effective hypertension management.
Frontiers Oct-24 Research published in Frontiers highlights the validation of a photoplethysmography-based cuffless blood pressure monitor capable of non-invasive tracking. This development marks a significant advancement in sensor-based cardiovascular monitoring, supporting the pipeline for next-generation wearables designed to increase the accessibility and precision of continuous, long-term blood pressure measurement for patients.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Blood Pressure Monitoring Devices Market — Custom Segments

Segment Sub-Segment
Patient Segment Adult Patients, Pediatric Patients, Geriatric Patients, High-Risk Patients
Clinical Application Hypertension Management, Cardiovascular Disease Monitoring, Critical Care Monitoring, Pregnancy-Related Blood Pressure Monitoring
Distribution Channel Direct Sales, Medical Device Distributors, Retail & Pharmacy, E-Commerce

Blood Pressure Monitoring Devices Market — Custom

Custom Chapter Custom Details
Hypertension Management Ecosystem Analysis
  • Hypertension Care Pathway Evolution
  • Stakeholder Roles Across Prevention, Diagnosis, and Management
  • Monitoring Technologies and Care Delivery Models
  • Integration of Blood Pressure Monitoring into Chronic Care Programs
  • Emerging Opportunities Across the Hypertension Management Ecosystem
Home Monitoring Adoption Assessment
  • Drivers of Home Blood Pressure Monitoring Adoption
  • Patient Engagement and Self-Monitoring Practices
  • Device Usability, Connectivity, and Digital Experience
  • Provider Integration and Remote Oversight Models
  • Barriers to Sustained Home Monitoring
Reimbursement & Access Landscape
  • Coverage and Reimbursement Model Evolution
  • Patient Access and Affordability Considerations
  • Provider and Payer Adoption Incentives
  • Policy Developments Influencing Home and Remote Monitoring
  • Strategic Implications for Market Access

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the blood pressure monitoring devices market?

As of 2027 the market size of blood pressure monitoring devices is valued at USD 4.94 billion.

How much is the blood pressure monitoring devices industry expected to grow by 2036?

Blood Pressure Monitoring Devices Market size was valued at USD 4.6 billion in 2026 and is anticipated to grow at a 8.84% CAGR from 2027 to 2036, attaining USD 10.73 billion by 2036.

How is the expansion of remote care reshaping demand in the blood pressure monitoring devices market?

Connected home monitoring devices are becoming central to hypertension management as healthcare providers increasingly rely on wireless data sharing, telehealth integration, and continuous trend analysis outside clinical settings.

What factors are driving institutional procurement in the blood pressure monitoring devices market?

Hospitals increasingly favor interoperable, clinically validated blood pressure monitoring systems that integrate with broader patient monitoring workflows, electronic records, and centralized care platforms to improve operational efficiency.

Why do Non-Smart/Traditional devices remain the largest segment in the blood pressure monitoring devices market?

Non-Smart/Traditional devices lead the market due to their broad familiarity, ease of use, and established role in routine blood pressure measurement across both clinical and personal monitoring settings.

What is driving the rapid growth of smart blood pressure monitoring devices?

Smart devices are the fastest-growing segment because they support connected health management and ongoing tracking. Their ability to integrate monitoring with digital care routines is increasing adoption among users seeking accessible health data.

What makes North America the leading blood pressure monitoring devices market?

North America held a 37.92% market share in 2026, supported by strong home monitoring adoption, established screening practices, mature healthcare systems, and broad availability of connected devices.

What is driving rapid growth of the blood pressure monitoring devices market in Asia Pacific?

Asia Pacific is projected to grow at an 11.07% CAGR, fueled by rising hypertension detection, expanding healthcare access, and increasing consumer adoption of affordable digital blood pressure monitors for home use.

Who are the leading players in the blood pressure monitoring devices landscape?

Major players in the blood pressure monitoring devices market include Omron Healthcare Co., Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Welch Allyn, Inc. (United States), A&D Company, Limited (Japan), SunTech Medical, Inc. (United States), Microlife Corporation (Taiwan), Rossmax International Ltd. (Taiwan), Spacelabs Healthcare, Inc. (United States), B. Braun SE (Germany).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →